Angiotensin I, angiotensin II and their biologically active peptides
- 1 May 2002
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hypertension
- Vol. 20 (5), 805-807
- https://doi.org/10.1097/00004872-200205000-00004
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Biological properties of the angiotensin peptides other than angiotensin II: implications for hypertension and cardiovascular diseasesJournal of Hypertension, 2002
- Vasodilator Action of Angiotensin-(1-7) on Isolated Rabbit Afferent ArteriolesHypertension, 2002
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and NephropathyNew England Journal of Medicine, 2001
- The angiotensin system elements in invertebratesBrain Research Reviews, 2001
- Inhibition of Early Atherogenesis by Losartan in Monkeys With Diet-Induced HypercholesterolemiaCirculation, 2000
- Novel mechanisms linking angiotensin II and early atherogenesisJournal of the Renin-Angiotensin-Aldosterone System, 2000
- Cardiovascular effects of angiotensin-(1-7) in conscious spontaneously hypertensive rats.Hypertension, 1999
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Angiotensin-(1-7): a new hormone of the angiotensin system.Hypertension, 1991